Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 67 (TMEM67), also known as Meckelin, is a 995-amino acid, multi-pass transmembrane protein essential for the formation and function of primary cilia in mammalian cells[2][3][6]. It is a component of the tectonic-like complex, required for tissue-specific ciliogenesis and regulation of ciliary membrane composition[6]. TMEM67 is critical for centriole migration to the apical cell surface during early ciliogenesis, regulation of centrosome duplication, and the negative regulation of canonical Wnt signaling while activating non-canonical Wnt pathways (notably as a co-receptor for Wnt5A and ROR2)[2][4][1]. The protein has a complex structure with an extracellular cysteine-rich domain, a β sheet–rich region, seven transmembrane helices, and a cytosolic coiled-coil domain. Mutations in TMEM67 cause several ciliopathies, including Meckel syndrome type 3, Joubert syndrome type 6, and nephronophthisis, highlighting its essential role in human development and disease[1][3][6]. There is currently no evidence TMEM67 is directly targeted by any approved drugs[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 67 (TMEM67).